REGENERON PHARMACEUTICALS, INC. (REGN)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 29, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, REGENERON PHARMACEUTICALS, INC. reported revenue of $4.29B, net income of $1.30B, and total assets of $41.73B. Every figure below is taken directly from REGENERON PHARMACEUTICALS, INC.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2025 · as reported
- FY2016 revenue
- $4.86B
- FY2025 revenue
- $14.34B
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $14.34B | $4.50B |
| FY2024 | $14.20B | $4.41B |
| FY2023 | $13.12B | $3.95B |
| FY2022 | $12.17B | $4.34B |
| FY2021 | $16.07B | $8.08B |
| FY2020 | $8.50B | $3.51B |
| FY2019 | $6.56B | $2.12B |
| FY2018 | $5.15B | $2.44B |
| FY2017 | $5.87B | $1.20B |
| FY2016 | $4.86B | $895.5M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 6, 2026 | on EDGAR ↗ |
| 8-K | Sep 30, 2026 | on EDGAR ↗ |
| 13F-HR | Aug 7, 2026 | on EDGAR ↗ |
| 10-Q | Jul 30, 2026 | on EDGAR ↗ |
| 8-K | Jul 30, 2026 | on EDGAR ↗ |
| 8-K | Jul 6, 2026 | on EDGAR ↗ |
| 8-K | Jun 17, 2026 | on EDGAR ↗ |
| 13F-HR | May 8, 2026 | on EDGAR ↗ |
| 8-K | Apr 29, 2026 | on EDGAR ↗ |
| 10-Q | Apr 29, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $12.23 | Earnings | source ↗ |
| EPS (basic) | $12.62 | Earnings | source ↗ |
| Shares Outstanding | — | — | source ↗ |
| Cash from Operations | $813.0M | Net | source ↗ |
| Cash from Financing | -$1.22B | Net | source ↗ |
| Cash from Investing | -$92.7M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 33
- Net shares
- -8.3K
Restatement history
Point-in-time24 of 478 annual fact-keys were materially restated between filings: what REGENERON PHARMACEUTICALS, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches REGN’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/REGN
MCP tool:
get_sec_fundamentals ticker=REGN - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/REGN/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=REGN as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/REGN/history
MCP tool:
get_fundamentals_history ticker=REGN - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/REGN
MCP tool:
get_financial_health ticker=REGN
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.